科研之友
微信
新浪微博
Facebook
分享链接
摘要
Objectives. This study investigated the association between polymorphisms in the receptor for advanced glycation end products (RAGE) gene and the susceptibility to diabetic retinopathy (DR) in a Chinese population and identified a correlation between serum-soluble RAGE (sRAGE) levels and DR risk. Materials and Methods. We enrolled 1040 patients with type 2 diabetes mellitus: 372 patients withDR and 668 without retinopathy (NDR). All polymorphisms were genotyped by time-of-flight mass spectrometry. Serumlevels of sRAGEwere assayed by enzyme-linked immunosorbent assays. The interaction of SNPs was analyzed bymultifactor dimensionality reduction (MDR). Results. The frequency of the SS genotype for theG82S polymorphismwas 12.4% in theDR group and 6.6% in the NDR group; this difference was significant. G82S was associated with sRAGE levels. Specifically, after adjustments for age, sex, duration, and glucose metabolism, serum sRAGE levels were significantly higher in DR subjects with the S/S genotype than inNDR subjects in general. In theDR group, subjects with the G/S genotype had lower sRAGE levels than subjects with the G/G or S/S genotype (p< 0.01). The best multilocus genetic interaction model was assessed using the MDR method; 2184A/G, 1704G/T, G82S, and -429T/C were identified. Conclusions. The findings suggest that the G82S polymorphism in the RAGE gene is associated with DR risk, and G82S was associated with circulating levels of sRAGE. The mechanism by which G82S polymorphism modulates the sRAGE levels remains to be elucidated.
